About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 376 record(s)
Req # A-2021-000365
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03829948.Organization: Health Canada
August 2021
Req # A-2021-000391
Adverse Drug Reaction (ADR) for Misoprostol. Report number: 000939353.Organization: Health Canada
August 2021
Req # A-2021-000407
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106413-934.Organization: Health Canada
August 2021
Req # A-2021-000421
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-102128-191.Organization: Health Canada
August 2021
Req # A-2021-000436
Adverse Drug Reaction (ADR). Report number: E2B_02553900.Organization: Health Canada
August 2021
Req # A-2021-000437
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100901-187.Organization: Health Canada
August 2021
Req # A-2021-000461
Adverse Reaction Reports (AERs) for Fluanxol. Report numbers: E2B_03459686, E2B_03464445, E2B_03468294, E2B_03464485, E2B_03468336, E2B_03464487, E2B_03464451, E2B_03464474, E2B_03459110, E2B_03452134, E2B_03452232, E2B_03452261, E2B_03346426, E2B_03337263.Organization: Health Canada
August 2021
Req # A-2021-000509
Adverse Reaction Reports (AERs) for TUBERCULIN TEST. Report numbers: 000924327, 000929098, 000928605.Organization: Health Canada
August 2021
Req # A-2021-000544
Adverse Reaction Reports (AERs) for LEUPROLIDE ACETATE. Report numbers: E2B_03413381, E2B_03413387, 000926931.Organization: Health Canada
August 2021
Req # A-2021-000545
Adverse Drug Reaction (ADR) for ALIROCUMAB. Report number: E2B_03408783.Organization: Health Canada
August 2021